Journal: Scientific reports

Article Title: Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPAR? signaling and inhibiting the NF-?B and ERK1/2/AP-1/STAT3 pathways.

PMID/MRN: 27721381

Publication Date: 2016-Oct-10

Abstract:

The present study aimed to examine the anti-inflammatory actions of oleoylethanolamide (OEA) in lipopolysaccharide (LPS)-induced THP-1 cells. The cells were stimulated with LPS (1 ?g/ml) in the presence or absence of OEA (10, 20 and 40 ?M). The pro-inflammatory cytokines were evaluated by qRT-PCR and ELISA. The THP-1 cells were transiently transfected with PPAR? small-interfering RNA, and TLR4 activity was determined with a blocking test using anti-TLR4 antibody. Additionally, a special inhibitor was used to analyse the intracellular signaling pathway. OEA exerted a potent anti-inflammatory effect by reducing the production of pro-inflammatory cytokines and TLR4 expression, and by enhancing PPAR? expression. The modulatory effects of OEA on LPS-induced inflammation depended on PPAR? and TLR4. Importantly, OEA inhibited LPS-induced NF-?B activation, I?B? degradation, expression of AP-1, and the phosphorylation of ERK1/2 and STAT3. In summary, our results demonstrated that OEA exerts anti-inflammatory effects by enhancing PPAR? signaling, inhibiting the TLR4-mediated NF-?B signaling pathway, and interfering with the ERK1/2-dependent signaling cascade (TLR4/ERK1/2/AP-1/STAT3), which suggests that OEA may be a therapeutic agent for inflammatory diseases.